Accreditations & Awards
We’re proud of our accomplishments!
Maine Veterinary Medical Center
Accreditations, Accomplishments, and Participation in Peer-Reviewed Studies and Advancement in Veterinary Medicine
Antibiotic study: University of Minnesota
In August of 2021 Maine Veterinary Medical Center participated in an Antibiotic Use Point-Prevalence Survey being conducted by College of Veterinary Medicine at the University of Minnesota as part of their Antimicrobial Resistance and Stewardship Initiative. These types of studies are structured to collect uniform data from multiple sites over a specific period of time. On a specific day in 2021, a trained facility coordinator collected retrospective data at Maine Veterinary Medical Center using existing health records. Data from all participating clinics was then compiled to summarize patient characteristics and presenting complaints, antibiotic prescribing rates, rates of diagnostic testing, and more.
The goal of this study is to establish a national estimate of antibiotic usage in general and referral small animal clinics and to describe how and why antibiotics are prescribed to small animal patients. This information will be used to identify antibiotic stewardship objectives, define interventions to improve prescribing, and track progress.
Learn more here.
LSU Blood Transfusion Study
MVMC is proud to partner with Louisiana State University in a large, multi-institutional study evaluating the incidence of blood transfusion reactions in relation to transfusion administration rate in dogs and cats. This study will help improve the quality of transfusion medicine in our patients and develop safer guidelines for clinical practice.
LSU Blood Transfusion Study
MVMC is proud to partner with Louisiana State University in a large, multi-institutional study evaluating the incidence of blood transfusion reactions in relation to transfusion administration rate in dogs and cats. This study will help improve the quality of transfusion medicine in our patients and develop safer guidelines for clinical practice.
VetCOT Level 2 Certification
Rigorous certification involves instituting high stands of care and participating in the nation-wide trauma registry that disseminates information that improves trauma patient management efficiency and outcome.
Learn more here.
VECCS Level I Certification
A Level I emergency and critical care facility has the specialized medical staff, support personnel, equipment, and training necessary to provide sophisticated emergent and critical patient care. The Level I facility is open to receive small animal emergency patients 24 hours a day, 7 days a week, 365 days a year.
FidoCure - Targeted Therapy
FidoCure works by sequencing the DNA in a pet’s tumor cells to identify mutations that can be targeted by specific chemotherapy drugs. The therapy is delivered in pill form in the comforts of their own home.
Learn more here.
Gilvetmab – Monoclonal Antibody Treatment
Gilvetmab is a caninized monoclonal antibody used to treat dogs with MCTs and melanomas. It is an ideal systemic treatment option labeled for dogs with stage I, II, and III MCTs and stage II and III melanomas.
Learn more with the links below:
Immunotherapy (augmented T-cell therapy for canine osteosarcoma with Elias Animal Health)
A unique treatment protocol that vaccinates the dog with its own cancer cells to produce an immune response. Personalized T cells are then safely obtained from the patient through apheresis and activated to produce a large population of killer T cells that are reinfused into the patient to kill the cancer.
Learn more here.